ArticleEuropean journal of cancer (Oxford, England : 1990)2020

COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors.

Alessandro Leonetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.